Ledger.Open graph →
SEC Form D · Amendment · filed October 6, 2015

Metacrine, Inc

Offering
$36.4M
Sold
$12.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kristina Burow · San Diego, CADirectorAmir Nashat · San Diego, CADirectorRobert Adelman · San Diego, CADirectorRichard Heyman · San Diego, CADirectorTrisha Millican · San Diego, CAExecRonald Evans · San Diego, CADirectorMatthew Ginsberg · Eugene, ORDirectorWilliams M. Clark · Austin, TXDirectorAlaina Danley · Grand Cayman, Cayman IslandsDirectorJerrold C. Miller · DENVER, COExecNeil Mcdonnell · San Diego, CAExec · DirectorLilly J. Farahnakian · Chicago, ILDirectorDennis Capovilla · Eugene, ORDirectorJames Deters · DENVER, CODirectorLawrence C. Mandes · DENVER, CODirectorJ. D. Duebendorfer · New York, NYExecMurray Markiles · Sherman Oaks, CADirectorNeil Mcdonnell · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗